SCHEMBL8951503

SCHEMBL8951503

CCC#CC[Sn](CCCC)(CCCC)CCCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20658212 0.92 TSHR (0.33)
SCHEMBL20658199 0.82 TSHR (0.42)
SCHEMBL14914835 0.80 RAB9A (0.33)
SCHEMBL2430231 0.72 TSHR (0.43)
SCHEMBL1042228 0.72 SMN1; SMN2 (0.31)
SCHEMBL135552 0.71 TSHR (0.46)
SCHEMBL28438742 0.71 TSHR (0.46)
SCHEMBL2139803 0.68 TSHR (0.43)
SCHEMBL3577655 0.68 TSHR (0.43)
Hydrochloric Acid SCHEMBL336735 0.68 TSHR (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0745071-A1 4-AMINO 6-SUBSTITUTED MYCOPHENOLIC ACID AND DERIVATIVES WITH IMMUNOSUPPRESSIVE ACTIVITY SYNTEX (U.S.A.) INC. (US) 1996-12-04 EP disclosed
EP-0745075-A1 6-SUBSTITUTED MYCOPHENOLIC AND DERIVATIVES WITH IMMUNOSUPPRESSIVE ACTIVITY SYNTEX (U.S.A.) INC. (US) 1996-12-04 EP disclosed
US-5554612-A IMMUNOSUPPRESSANTS, VIRICIDES, ANTITUMOR AND ANTIINFLAMMATORY AGENTS SYNTEX INC (US) 1996-09-10 US disclosed
US-5536747-A ENZYME INHIBITORS SYNTEX (U.S.A.) INC. (US) 1996-07-16 US disclosed
US-5525602-A TREATING INFLAMMATORY DISEASES, PREVENTING ALLOGRAFT REJECTION, AUTOIMMUNE DISEASES SYNTEX (U.S.A.) INC. (US) 1996-06-11 US disclosed
WO-1995022534-A1 4-AMINO 6-SUBSTITUTED MYCOPHENOLIC ACID AND DERIVATIVES WITH IMMUNOSUPPRESSIVE ACTIVITY SYNTEX (U.S.A.) INC. (US) 1995-08-24 WO disclosed
WO-1995022536-A1 6-SUBSTITUTED MYCOPHENOLIC AND DERIVATIVES WITH IMMUNOSUPPRESSIVE ACTIVITY SYNTEX (U.S.A.) INC. (US) 1995-08-24 WO disclosed
US-5444072-A Useful in treatment of autoimmune disorders, psoriasis, inflammatory diseases, rheumatoid arthritis SYNTEX (U.S.A.) INC. (US) 1995-08-22 US disclosed